MedPath

Acupuncture for Low-Dose Opioid for TKA Replacement

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Pain, Postoperative
Acupuncture
Registration Number
NCT04084288
Lead Sponsor
Hospital for Special Surgery, New York
Brief Summary

The majority of patients undergoing total knee replacement(TKR) rely on opioids for postoperative analgesia. These medications have undesirable side effects and potential for abuse and addiction. The aim of this cohort study is to determine the incidence rate of patients who are able to maintain a low dose opioid regimen after TKR with the use of a multimodal approach that includes intraoperative auricular acupuncture protocol.

Detailed Description

This is a prospective cohort study to assess the feasibility of patients to undergo TKR while adhering to a low-dose opioid regimen by using a multimodal analgesic approach that includes intraoperativeauricular acupuncture. We hypothesize that it will be feasible to maintain a low-dose opioid regimen during TKR while followingthe intraoperative auricular acupuncture protocol, and that patients will be satisfied with their pain control with a low incidence of adverse events.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • ASA of 1 or 2
  • Age 18-70
  • Undergoing primary total knee replacement
  • Desire to attempt a low opioid or opioid free pathway
Exclusion Criteria
  • NonEnglish speaking
  • Patients with the inability to understand or follow study protocol
  • Opioid use in the last 6 weeks or chronic pain patient
  • Cannot receive neuraxial anesthesia and/or peripheral nerve block
  • Patients with contraindications to intraop protocol (e.g., patient cannot take acetaminophen or ketorolac due to liver or kidney disease)
  • Patients with implanted cardiac device such as a pacemaker or AICD
  • Active ear infection
  • Nonnative ear, previous scarring or surgical manipulation of ear
  • Patients with gauges or other deforming ear piercing (small nondeforming ear piercings are ok) present in ears
  • Allergy to nickel

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Low-dose Opioid Regimen Adherencepostoperative day 0 to postoperative day 30

The number of patients who maintain a low-dose opioid regimen (15 pills or less of 5mg oxycodone or 112.5 OME \[oral morphine equivalents\]) from postoperative day (POD) 0 to POD 30 throughout their Total Knee Replacement.

Secondary Outcome Measures
NameTimeMethod
Total Opioid Consumptionpost anesthesia care unit (PACU), postoperative day (POD) 1, POD7, POD14, POD30

Postoperative opioid consumption measured in oral morphine equivalents (OME) at various timepoints

Numerical Rating Scale (NRS) Pain Scores at Rest and With Movementpost anesthesia care unit (PACU), postoperative day (POD) 1, POD7, POD14, POD30

Numerical Rating Scale (NRS) pain scores at rest and with movement. NRS pain is measured from 0 to 10, with 0 being the no pain whatsoever and 10 being the worst pain imaginable.

Duration of Neuraxial Anesthesia in Hourspostoperative day 1

Duration of neuraxial anesthesia is defined as number of hours between anesthesia start time to anesthesia stop time.

Deviation From Prescribed Oral Pain RegimenPostoperative day 30

Tracking the number of patients that received different oral pain main medication, including the need for rescue medications by postoperative day 30

Number of Participants With Side Effects on POD1 and During the PACU StayPACU, Postoperative day 1

Incidence of nausea, vomiting, pruritus (itching), and constipation. These are reported by the patient in the PACU and on postoperative day 1

Postoperative Range of Motion6 weeks postoperative (surgeon office visit)

Postoperative range of motion measured at the 6 week surgeon office visit. This is being measured by either the physician or their PA and is a score that is achieved by adding extension and flexion together. It is measured in degrees. (example: flexion: 118 + extension:1 = score: 119)

Tourniquet TimeIntraoperatively

Duration of time the tourniquet is inflated intraoperatively. Measured in minutes

Trial Locations

Locations (1)

Hospital for Special Surgery

🇺🇸

New York, New York, United States

Hospital for Special Surgery
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.